Search research articles
Contact Us
Filters
Showing results (261-270 of 283) with videos related to
Page
of 29
Sort By:
European Journal of Gastroenterology & Hepatology
|
December 8, 2016
Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies
Sanne J H Van Erp, Marije K Verheul, E W Nivine Levarht, et al.
Clinical and Experimental Immunology
|
April 24, 2013
Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis
L A Trouw, N Daha, F A S Kurreeman, et al.
Annals of the Rheumatic Diseases
|
November 29, 2025
Dimerization as a key feature of autoreactive IgA antibody responses
Anouk G van Mourik, Jim B D Keijser, Myrthe A M van Delft, et al.
Clinical and Experimental Immunology
|
December 20, 2019
Carbamylation reduces the capacity of IgG for hexamerization and complement activation
R Lubbers, S C Oostindie, D J Dijkstra, et al.
Scientific Reports
|
July 18, 2023
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
Paula Niewold, Douwe J Dijkstra, Yi Cai, et al.
Annals of the Rheumatic Diseases
|
June 14, 2011
Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis
Hans Ulrich Scherer, Diane van der Woude, Annemiek Willemze, et al.
Immunobiology
|
December 3, 2014
Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections
Rosanne A van Schaarenburg, Nina A Daha, Joris J M Schonkeren, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 24, 2008
Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1
Susan M Westaway, Mervyn Thompson, Harshad K Rami, et al.
Science Translational Medicine
|
June 5, 2015
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
Helen Benham, Hendrik J Nel, Soi Cheng Law, et al.
Arthritis Research & Therapy
|
September 4, 2021
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
Sanne Reijm, Theresa Kissel, Gerrie Stoeken-Rijsbergen, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 283) with videos related to
Sort By:
Page
of 29
European Journal of Gastroenterology & Hepatology
|
December 8, 2016
Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies
Sanne J H Van Erp, Marije K Verheul, E W Nivine Levarht, et al.
Clinical and Experimental Immunology
|
April 24, 2013
Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis
L A Trouw, N Daha, F A S Kurreeman, et al.
Annals of the Rheumatic Diseases
|
November 29, 2025
Dimerization as a key feature of autoreactive IgA antibody responses
Anouk G van Mourik, Jim B D Keijser, Myrthe A M van Delft, et al.
Clinical and Experimental Immunology
|
December 20, 2019
Carbamylation reduces the capacity of IgG for hexamerization and complement activation
R Lubbers, S C Oostindie, D J Dijkstra, et al.
Scientific Reports
|
July 18, 2023
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
Paula Niewold, Douwe J Dijkstra, Yi Cai, et al.
Annals of the Rheumatic Diseases
|
June 14, 2011
Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis
Hans Ulrich Scherer, Diane van der Woude, Annemiek Willemze, et al.
Immunobiology
|
December 3, 2014
Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections
Rosanne A van Schaarenburg, Nina A Daha, Joris J M Schonkeren, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 24, 2008
Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1
Susan M Westaway, Mervyn Thompson, Harshad K Rami, et al.
Science Translational Medicine
|
June 5, 2015
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
Helen Benham, Hendrik J Nel, Soi Cheng Law, et al.
Arthritis Research & Therapy
|
September 4, 2021
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
Sanne Reijm, Theresa Kissel, Gerrie Stoeken-Rijsbergen, et al.
Page
of 29